preclamol has been researched along with Huntington Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bezprozvanny, IB; Bol'shakova, AV; Gainullina, AN; Kraskovskaya, NA; Kukanova, EO; Vlasova, OL | 1 |
| Bezprozvanny, I; Geva, M; Grossman, I; Hayden, M; Kusko, R; Ryskamp, D; Wu, J | 1 |
2 other study(ies) available for preclamol and Huntington Disease
| Article | Year |
|---|---|
Neuroprotective Effect of σ1-Receptors on the Cell Model of Huntington's Disease.
Topics: Animals; Anisoles; Calcium; Cerebral Cortex; Corpus Striatum; Dendritic Spines; Gene Expression; Homeostasis; Huntington Disease; Male; Mice; Models, Biological; Morpholines; Neurons; Piperidines; Primary Cell Culture; Propylamines; Receptors, sigma; RNA, Small Interfering; Sigma-1 Receptor; Synapses; Synaptic Transmission; Transduction, Genetic | 2017 |
The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease.
Topics: Aging; Animals; Calbindins; Calcium; Cations, Divalent; Coculture Techniques; Corpus Striatum; Dendritic Spines; Disease Models, Animal; Endoplasmic Reticulum; Humans; Huntington Disease; Mice; Mice, Transgenic; Neuroprotective Agents; Piperidines; Rats, Inbred SHR; Receptors, sigma; Sigma-1 Receptor; Synapses | 2017 |